Less Ads, More Data, More Tools Register for FREE

Pin to quick picksH&t Group Plc Regulatory News (HAT)

  • This share is currently suspended. It was suspended at a price of 650.00
  • There is currently no data for HAT

Replacement: Form 8.3

20 May 2025 17:14

RNS Number : 4734J
H&T Group PLC
20 May 2025
 

AMENDMENT CHANGES TO SECTION 1(c). REPLACES RNS 4574J.

 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Fiduchi Trustees Limited in its capacity as trustee of the H&T Group plc Employee Benefit Trust

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Trustee: Fiduchi Trustees Limited

Settlor: H&T Group PLC

Beneficiaries: employees and former employees of the H&T group, including certain of their dependants, spouses, civil partners and surviving spouses and civil partners, in accordance with the trust deed.

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

H&T Group Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

NA

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

20 May 2025

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

Ordinary Shares 5p

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

476,224

1.08

 

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

 

476,224

 

1.08

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

N/A - none

 

 

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

N/A - none

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

N/A - none

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

N/A - none

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

N/A - none

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

20 May 2025

Contact name:

Tom Hicks

Telephone number*:

07829 931 001

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETFLFLREIIIFIE
Date   Source Headline
29th Sep 20224:43 pmRNSProposed Capital Raise of up to £16.9m
9th Sep 20227:00 amRNSAppointment of Non-Executive Director
18th Aug 202210:33 amRNSHolding(s) in Company
17th Aug 20225:20 pmRNSStandard form for notification of major holdings
9th Aug 20227:00 amRNSInterim Results
8th Jul 20229:08 amRNSHolding(s) in Company
6th Jul 20224:35 pmRNSPrice Monitoring Extension
4th Jul 20227:01 amRNSAcquisition of Swiss Time Services Limited
4th Jul 20227:00 amRNSTrading Update and Notice of Results
29th Jun 20226:18 pmRNSHolding(s) in Company
30th May 20227:00 amRNSPerformance Share Plan ("PSP") 2022
13th May 20227:00 amRNSResult of AGM
12th May 20227:00 amRNSTrading Update
3rd May 20224:35 pmRNSPrice Monitoring Extension
28th Apr 20223:22 pmRNSHolding(s) in Company
26th Apr 20227:00 amRNSAppointment of non-executive director
4th Apr 20227:00 amRNSUpdate on regulatory review into HCST lending
25th Mar 20221:49 pmRNSHolding(s) in Company
8th Mar 20227:00 amRNSPreliminary results for the year ended 31 Dec 2021
17th Jan 20227:00 amRNSTrading Update and Notice of Results
17th Jan 20227:00 amRNSChange of Nominated Adviser and Broker
20th Dec 20217:00 amRNSAnnouncement – Rule 17 Schedule 2(g) Updated
24th Nov 20219:52 amRNSDirector appointed
19th Nov 202112:08 pmRNSHolding(s) in Company
2nd Nov 20217:00 amRNSNotification of major holdings
1st Nov 202110:22 amRNSH&T CFO appointment update
5th Oct 20212:30 pmRNSNotification of major holdings
10th Aug 20217:00 amRNSCorrection to Ex-Dividend and Record Date
9th Aug 20217:00 amRNSChief Finance Officer Appointment
9th Aug 20217:00 amRNSUnaudited Interim Results
21st Jul 20217:00 amRNSNotice of Interim Results
5th Jul 202111:56 amRNSPDMR Dealing
20th May 20213:00 pmRNSResult of Annual General Meeting
30th Apr 20217:00 amRNSBoard Changes - Chief Financial Officer
26th Apr 20217:00 amRNSPosting of Report & Accounts and Notice of AGM
23rd Mar 20217:00 amRNSPreliminary results for the year ended 31 Dec 2020
22nd Feb 20217:00 amRNSNotification of major holdings
25th Jan 20217:00 amRNSTRADING UPDATE AND NOTICE OF RESULTS
20th Nov 20207:00 amRNSDirector Dealings
9th Nov 20205:22 pmRNSChange of Auditor
5th Nov 202011:00 amRNSBusiness update
2nd Nov 20207:00 amRNSChange of Auditor
29th Oct 20207:00 amRNSH&T CEO appointment
26th Oct 20207:00 amRNSDirectorate Change
13th Oct 20204:35 pmRNSPrice Monitoring Extension
25th Sep 20207:00 amRNSDirector Dealings
25th Aug 20204:35 pmRNSPrice Monitoring Extension
14th Aug 20208:37 amRNSTR-1: Notification of major holdings
13th Aug 20201:50 pmRNSAIM Rule 17 disclosure
11th Aug 20202:50 pmRNSInterim Results – Correction

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.